The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Hot-spot analysis for drug discovery targeting protein-protein interactions
Open accessAbstract
INTRODUCTION: Protein-protein interactions are important for biological processes and pathological situations, and are attractive targets for drug discovery. However, rational drug design targeting protein-protein interactions is still highly challenging. Hot-spot residues are seen as the best option to target such interactions, but their identification requires detailed structural and energetic characterization, which is only available for a tiny fraction of protein interactions. Areas covered: In this review, the authors cover a variety of computational methods that have been reported for the energetic analysis of protein-protein interfaces in search of hot-spots, and the structural modeling of protein-protein complexes by docking. This can help to rationalize the discovery of small-molecule inhibitors of protein-protein interfaces of therapeutic interest. Computational analysis and docking can help to locate the interface, molecular dynamics can be used to find suitable cavities, and hot-spot predictions can focus the search for inhibitors of protein-protein interactions. Expert opinion: A major difficulty for applying rational drug design methods to protein-protein interactions is that in the majority of cases the complex structure is not available. Fortunately, computational docking can complement experimental data. An interesting aspect to explore in the future is the integration of these strategies for targeting PPIs with large-scale mutational analysis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, abnormalities in PPIs can result in a various diseases, such as cancers, infectious diseases, and neurodegenerative diseases.306–308”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [308]
Citations
Cites
Protein folding and misfolding
Dobson, C. M. (2003) · Nature · doi:10.1038/nature02261 · Cited by 4,791
From molecular to modular cell biology.
Hartwell, L. H., Hopfield, J. J., Leibler, S., & Murray, A. W. (1999) · Nature · doi:10.1038/35011540 · Cited by 3,632
Goh, K.-I., Cusick, M. E., Valle, D., Childs, B., Vidal, M., & Barabási, A.-L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701361104 · Cited by 3,242
HADDOCK: A Protein−Protein Docking Approach Based on Biochemical or Biophysical Information
Dominguez, C., Boelens, R., & Bonvin, A. M. J. J. (2003) · Journal of the American Chemical Society · doi:10.1021/ja026939x · Cited by 3,187
PatchDock and SymmDock: servers for rigid and symmetric docking
Schneidman-Duhovny, D., Inbar, Y., Nussinov, R., & Wolfson, H. J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki481 · Cited by 3,018
Towards a proteome-scale map of the human protein–protein interaction network
Rual, J.-F. M., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N., Berriz, G. F., Gibbons, F. D., Dreze, M., Ayivi-Guedehoussou, N., et al. (2005) · Nature · doi:10.1038/nature04209 · Cited by 2,904
The FoldX web server: an online force field
Schymkowitz, J., Borg, J., Stricher, F., Nys, R., Rousseau, F., & Serrano, L. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki387 · Cited by 2,759 · cited 2×
“Some examples of this strategy are HSPred [50], Rosetta [51] and FoldX [52].”
MethodPhase transitions in the assembly of multivalent signalling proteins
Li, P., Banjade, S., Cheng, H., Kim, S., Chen, B., Guo, L., Llaguno, M. C., Hollingsworth, J. V., King, D., Banani, S. F., et al. (2012) · Nature · doi:10.1038/nature10879 · Cited by 2,565
A comprehensive map of molecular drug targets
Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., et al. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.230 · Cited by 2,427
A geometric approach to macromolecule-ligand interactions
Kuntz, I. D., Blaney, J. M., Oatley, S. J., Langridge, R., & Ferrin, T. E. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90153-x · Cited by 2,287
Research works printed but not linked: 1
- Wilson CGM, 2011, Curr Top Microbiol Immunol, 348, 25
Cited by
Sorted by citations
Lu, H., Zhou, Q., He, J., Jiang, Z., Peng, C., Tong, R., & Shi, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00315-3 · Cited by 891
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396
New insights into protein–protein interaction modulators in drug discovery and therapeutic advance
Nada, H., Choi, Y., Kim, S.-D., Jeong, K. S., Meanwell, N. A., & Lee, K. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02036-3 · Cited by 241
Aromatic clusters in protein–protein and protein–drug complexes
Lanzarotti, E., Defelipe, L. A., Marti, M. A., & Turjanski, A. G. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00437-4 · Cited by 102
BAlaS: fast, interactive and accessible computational alanine-scanning using BudeAlaScan
Wood, C. W., Ibarra, A. Á., Bartlett, G. J., Wilson, A. J., Woolfson, D. N., & Sessions, R. B. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa026 · Cited by 75
Small molecules targeting protein–protein interactions for cancer therapy
Wu, D., Li, Y., Zheng, L., Xiao, H., Ouyang, L., Wang, G., & Sun, Q. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.05.035 · Cited by 71
Zhou, Y., Myung, Y., Rodrigues, C. H. M., & Ascher, D. B. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae412 · Cited by 65
Fragment-based drug discovery supports drugging ‘undruggable’ protein–protein interactions
Wang, Z.-Z., Shi, X.-X., Huang, G.-Y., Hao, G., & Yang, G. (2023) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2023.01.008 · Cited by 66
Targeting protein-protein interaction interfaces in COVID-19 drug discovery
Chang, C., Lin, S., Satange, R., Lin, S., Sun, S.-C., Wu, H., Kehn‐Hall, K., & Hou, M. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.04.003 · Cited by 47
Computational methods-guided design of modulators targeting protein-protein interactions (PPIs)
Qiu, Y., Li, X., He, X., Pu, J., Zhang, J., & Lu, S. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112764 · Cited by 42
Machine learning methods for protein-protein binding affinity prediction in protein design
Guo, Z., & Yamaguchi, R. (2022) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2022.1065703 · Cited by 41
ProtInteract: A deep learning framework for predicting protein–protein interactions
Soleymani, F., Paquet, E., Viktor, H. L., Michalowski, W., & Spinello, D. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.01.028 · Cited by 41
Li, T., Liu, X., Qian, H., Zhang, S., Hou, Y., Zhang, Y., Luo, G., Zhu, X., Tao, Y., Fan, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51197-w · Cited by 37
Camps-Fajol, C., Cavero, D., Minguillón, J., & Surrallés, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107544 · Cited by 36
Özdemir, E. S., Halakou, F., Nussinov, R., Gürsoy, A., & Keskin, Ö. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8955-3_1 · Cited by 34
An Overview of Computational Methods, Tools, Servers, and Databases for Drug Repurposing
Sarvagalla, S., Syed, S. B., & Coumar, M. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00025-0 · Cited by 32
Docking-based identification of small-molecule binding sites at protein-protein interfaces
Rosell, M., & Fernández‐Recio, J. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.11.029 · Cited by 33
Self-citationTargeting protein–protein interactions in the DNA damage response pathways for cancer chemotherapy
McPherson, K. S., & Korzhnev, D. M. (2021) · RSC Chemical Biology · doi:10.1039/d1cb00101a · Cited by 35
Selective fluorescent labeling of cellular proteins and its biological applications
Choi, J. H., Kim, S., Kang, O., Choi, S. Y., Hyun, J. Y., Lee, H. S., & Shin, I. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00094c · Cited by 33
Panday, S. K., & Alexov, E. (2022) · ACS Omega · doi:10.1021/acsomega.1c07037 · Cited by 33
Hasan, M., Parvez, M. S. A., Azim, K. F., Imran, M. A. S., Raihan, T., Gulshan, A., Muhit, S., Akhand, M. R. N., Ahmed, S. S. U., & Uddin, M. B. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111742 · Cited by 25
Yan, J., Zheng, X., You, W., He, W., & Xu, G. (2022) · Advanced Science · doi:10.1002/advs.202105179 · Cited by 25
Xu, Y.-D., Guo, X.-Y., Yan, D., Dang, X., Guo, L., Jia, T., & Wang, Q. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00310 · Cited by 25
Nandi, S., Bhaduri, S., Das, D., Ghosh, P., Mandal, M., & Mitra, P. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c01161 · Cited by 28
Prediction and targeting of GPCR oligomer interfaces
Barreto, C. A. V., Baptista, S. J., Preto, A. J., Matos‐Filipe, P., Mourão, J., Melo, R., & Moreira, I. S. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.11.007 · Cited by 24
Proteomics for cancer drug design
Haymond, A. N., Davis, J. B., & Espina, V. A. (2019) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1650025 · Cited by 22
Decoding Protein-protein Interactions: An Overview
Slater, O., Miller, B., & Kontoyianni, M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200226105312 · Cited by 21
Nikam, R., Yugandhar, K., & Gromiha, M. M. (2023) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2023.140948 · Cited by 21
Trisciuzzi, D., Villoutreix, B. O., Siragusa, L., Baroni, M., Cruciani, G., & Nicolotti, O. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2218641 · Cited by 19
Obtaining Protein Association Energy Landscape for Integral Membrane Proteins
Rajagopal, N., & Nangia, S. (2019) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.9b00626 · Cited by 19
He, X., Huang, N., Qiu, Y., Zhang, J., Liu, Y., Yin, X., & Lu, S. (2021) · Molecules · doi:10.3390/molecules26040962 · Cited by 18
Sarvagalla, S., Lin, T., Kondapuram, S. K., Cheung, C. H. A., & Coumar, M. S. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.129619 · Cited by 17
Agrahari, A. K., Dikshit, M., & Asthana, S. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.07.008 · Cited by 18
Application of Nanopore Sensors for Biomolecular Interactions and Drug Discovery
Jeong, K., Kim, J., Dhanasekar, N. N., Lee, M., & Chi, S. (2022) · Chemistry - An Asian Journal · doi:10.1002/asia.202200679 · Cited by 16
Dike, P. P., Bhowmick, S., Eldesoky, G. E., Wabaidur, S. M., Patil, P. C., & Islam, M. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1835714 · Cited by 17
Cicaloni, V., Trezza, A., Pettini, F., & Spiga, O. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190304153901 · Cited by 16
Chen, B., Liu, C., Cong, W., Gao, F., Zou, Y., Su, L., Liu, L., Hillisch, A., Lehmann, L. E., Bierer, D. E., et al. (2023) · Chemical Science · doi:10.1039/d3sc04279k · Cited by 16
Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate
Abbas, H., Derkaoui, D. K., Jeammet, L., Adicéam, E., Tiollier, J., Sicard, H., Braun, T., & Poyet, J. (2024) · Biomolecules · doi:10.3390/biom14010136 · Cited by 16
Using machine‐learning‐driven approaches to boost hot‐spot's knowledge
Rosário‐Ferreira, N., Bonvin, A. M. J. J., & Moreira, I. S. (2022) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1602 · Cited by 14
Barthel, T., Wollenhaupt, J., Lima, G. M. A., Wahl, M. C., & Weiss, M. S. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01165 · Cited by 14
ProBAN : Neural network algorithm for predicting binding affinity in protein–protein complexes
Bogdanova, E. A., & Novoseletsky, V. N. (2024) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26700 · Cited by 13
Singh, A. K., Wadsworth, P. A., Tapia, C. M., Aceto, G., Ali, S. R., Chen, H., D’Ascenzo, M., Zhou, J., & Laezza, F. (2020) · Physiological Reports · doi:10.14814/phy2.14505 · Cited by 13
Junaid, M., Li, C., Shah, M., Khan, A., Guo, H., & Wei, D. (2019) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25748 · Cited by 12
Structural insights into Beclin 1 interactions with it's regulators for autophagy modulation
Sarmadhikari, D., & Asthana, S. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.06.044 · Cited by 13
Unleashing the power of DNA-encoded libraries for challenging targets in drug discovery
Du, N., Li, Y., Lou, Q., Zhang, G., Li, Y., & Li, Y. (2026) · Pharmaceutical Science Advances · doi:10.1016/j.pscia.2026.100115 · Cited by 10
Recent developments in the utility of saturated azaheterocycles in peptidomimetics
Singh, M. K., & Lakshman, M. K. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob01329g · Cited by 9
Akinnuwesi, A., Egieyeh, S. A., & Cloete, R. E. A. (2023) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2023.1254656 · Cited by 9
Cold spots are universal in protein–protein interactions
Gurusinghe, S. N. S., Oppenheimer, B., & Shifman, J. M. (2022) · Protein Science · doi:10.1002/pro.4435 · Cited by 8
Electrophile Scanning Reveals Reactivity Hotspots for the Design of Covalent Peptide Binders
Grob, N. M., Remarcik, C., Rössler, S. L., Wong, J. Y. K., Wang, J. C. K., Tao, J., Smith, C. L., Loas, A., Buchwald, S. L., Eaton, D., et al. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00538 · Cited by 9
Boyenle, I. D., Ogunlana, A. T., Oyedele, A.-Q. K., Olokodana, B. K., Owolabi, N., Salahudeen, A. K., Aderenle, O. T., Oloyede, T., & Adelusi, T. I. (2022) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2022.10.014 · Cited by 8
Du, J., Liu, L., Liu, B., Yang, J., Hou, X., Yu, J., & Fang, H. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2020-0114 · Cited by 8
Village Regrouping in the Eastern Plains of China: A Perspective on Home-Field Distance
Li, X., Liu, Y., Chen, Y., Li, P., & Yu, Z. (2019) · Sustainability · doi:10.3390/su11061630 · Cited by 8
Monte Carlo simulations using PELE to identify a protein–protein inhibitor binding site and pose
Díaz, L., Soler, D., Tresadern, G., Buyck, C., Pérez‐Benito, L., Saen‐oon, S., Guallar, V., & Soliva, R. (2020) · RSC Advances · doi:10.1039/d0ra01127d · Cited by 10
Structure-informed machine learning for drug discovery: a task-centric perspective
Li, Y., Zhan, R.-H., Rao, J., Liu, M., Sang, P., Zeng, X., Zheng, M., Li, X., & Yang, L. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag081 · Cited by 8
Sládek, V., Artiushenko, P. V., & Fedorov, D. G. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00973 · Cited by 8
Adikaram, P. R., Zhang, J., Kittock, C. M., Pandey, M., Hassan, S. A., Lue, N., Wang, G., Guček, M., & Simonds, W. F. (2019) · Communications Biology · doi:10.1038/s42003-019-0585-1 · Cited by 7
Protein-protein interactions: a structural view of inhibition strategies and the IL-23/IL-17 axis
Allen, S. J., & Lumb, K. J. (2020) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.12.006 · Cited by 7
Lesovoy, D., Roshchin, K., Sala, B. M., Sandalova, T., Achour, A., Agback, T., Agback, P., & Orekhov, V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188917 · Cited by 6
Computational Design of Peptide-Based Binders to Therapeutic Targets
Mulligan, V. K., & Hosseinzadeh, P. (2022) · ACS symposium series · doi:10.1021/bk-2022-1417.ch003 · Cited by 7
Computational methods for predicting hotspots at protein–RNA interfaces
Mei, L., Hao, G., & Yang, G. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1675 · Cited by 6
Computational Analysis of Protein–Protein Interactions in Motile T-Cells
Kumar, S., Fazil, M. H. U. T., Ahmad, K., Tripathy, M., Rajapakse, J. C., & Verma, N. K. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9036-8_18 · Cited by 6
Lesovoy, D., Roshchin, K., Sala, B. M., Sandalova, T., Achour, A., Agback, T., Orekhov, V., & Agback, P. (2025) · doi:10.1101/2025.02.07.637034 · Cited by 6
Liotta, L. A., Conrads, T. P., Howard, M. A., Araujo, R. P., & Petricoin, E. (2025) · Nature Reviews Methods Primers · doi:10.1038/s43586-025-00453-4 · Cited by 5
Choi, S., Son, S. H., Kim, M. Y., Na, I., Uversky, V. N., & Kim, C. G. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126526 · Cited by 5
Exploring computational tools for improved structural design and stability of helical AApeptides
Li, T., Song, S., & He, Y. J. (2023) · Supramolecular Materials · doi:10.1016/j.supmat.2023.100038 · Cited by 5
PPI-hotspotID for detecting protein–protein interaction hot spots from the free protein structure
Chen, Y. C., Sargsyan, K., Wright, J. D., Chen, Y., Huang, Y., & Lim, C. (2024) · eLife · doi:10.7554/elife.96643 · Cited by 10
Cossu, F., Sorrentino, L., Fagnani, E., Zaffaroni, M., Milani, M., Toni Giorgino, A., & Mastrangelo, E. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00518 · Cited by 5
Albuquerque, A., da Silva, H. C., Sartori, G., & da Silva, J. H. M. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1885492 · Cited by 9
Yazhini, A., Sandhya, S., & Srinivasan, N. (2021) · Current Research in Structural Biology · doi:10.1016/j.crstbi.2021.05.003 · Cited by 5
Jiang, M., Li, Y., Sun, B., Xu, S., Pan, T. S., & Li, Y. (2022) · Genes & Genomics · doi:10.1007/s13258-022-01352-8 · Cited by 4
Hot-Spot-Guided Generative Deep Learning for Drug-Like PPI Inhibitor Design
Sun, H., Li, J., Zhang, Y., Lin, S., Chen, J., Tan, H., Wang, R., Mao, X., Zhao, J., Li, R., et al. (2025) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-025-00756-w · Cited by 6
Targeting protein–protein interactions with reversible covalent modalities: Non‐cysteine chemistries
Basu, R., & Fletcher, S. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70377 · Cited by 3
Kumar, A. K., & Rathore, R. S. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2252077 · Cited by 3
Çınaroğlu, S. S., & Biggin, P. C. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01041 · Cited by 3
Granados-Tristán, A. L., Carrillo‐Tripp, M., Hernández-Luna, C. E., Herrera-Rodulfo, A. F., González-Escalante, L. A., Arriaga-Guerrero, A. L., Silva-Ramírez, B., Escobedo-Guajardo, B. L., Mercado-Hernández, R., de León, M. B., et al. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012936 · Cited by 3
Revisiting Protein–Protein Docking: A Systematic Evaluation Framework
Jiang, L., Zhang, K., Zhu, K., Wang, Y., Kang, Y., & Hou, T. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c01399 · Cited by 3
Prediction of protein interactions with function in protein (de-)phosphorylation
Vagiona, A.-C., Notopoulou, S., Zdráhal, Z., Gonçalves-Kulik, M., Petrakis, S., & Andrade-Navarro, M. A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0319084 · Cited by 4
Drug Design Methods to Regulate Protein–Protein Interactions
Poluri, K. M., Gulati, K., Tripathi, D. K., & Nagar, N. (2023) · Springer eBooks · doi:10.1007/978-981-99-2423-3_6 · Cited by 2
Wang, H., Xie, X., Li, X., Huang, W. J., Wu, L., JIN, W., & Liu, B. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.055921 · Cited by 2
MENSAdb: a thorough structural analysis of membrane protein dimers
Matos‐Filipe, P., Preto, A. J., Koukos, P. I., Mourão, J., Bonvin, A. M. J. J., & Moreira, I. S. (2021) · Database · doi:10.1093/database/baab013 · Cited by 2
Target-specific design of drug-like PPI inhibitors via hot-spot-guided generative deep learningPreprint
Sun, H., Li, J., Zhang, Y., Lin, S., Chen, J., Tan, H., Wang, R., Mao, X., Zhao, J., Li, R., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.29.620869 · Cited by 2
Kundil, V. T., Suresh, S. C., Chellappan, S., Kizhakkepurayil, A., Basheer, S. M., & Gangadharan, A. K. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11321-4 · Cited by 1
Zhang, L., Bian, Z., Wang, X., & Kong, L. (2025) · Biosystems · doi:10.1016/j.biosystems.2025.105688 · Cited by 1
Oliva, F., Musiani, F., Giorgetti, A., Rubeis, S. D., Sorokina, O., Armstrong, J. D., Carloni, P., & Ruggerone, P. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2022.1059593 · Cited by 1
Application of Post Solid-Phase Oxime Ligation to Fine-Tune Peptide–Protein Interactions
Zhao, X. Z., Liu, F., & Burke, T. R. (2020) · Molecules · doi:10.3390/molecules25122807 · Cited by 1
Chen, Y. C., Sargsyan, K., Wright, J. D., Chen, Y., Huang, Y., & Lim, C. (2023) · Research Square · doi:10.21203/rs.3.rs-3400169/v1 · Cited by 1
Chen, Y. C., Sargsyan, K., Wright, J. D., Chen, Y., Huang, Y., & Lim, C. (2024) · eLife · doi:10.7554/elife.96643.1 · Cited by 1
Chen, Y. C., Sargsyan, K., Wright, J. D., Chen, Y., Huang, Y., & Lim, C. (2024) · eLife · doi:10.7554/elife.96643.2 · Cited by 2
Kumar, A. K., & Rathore, R. S. (2022) · doi:10.22541/au.167101052.24746048/v1
Becht, A., Frączyk, J., Waśko, J., Menaszek, E., Kajdanek, J., Miłowska, K., & Kolesińska, B. (2023) · Journal of Peptide Science · doi:10.1002/psc.3537
Molecular recognition of anion binding proteins: Characterization and inhibition
Schuurs, Z. P. (2023) · Queensland University of Technology · doi:10.5204/thesis.eprints.246091
Chen, Y. C., Sargsyan, K., Wright, J. D., Chen, Y., Huang, Y., & Lim, C. (2024) · Research Square · doi:10.21203/rs.3.rs-3400169/v2
Chen, Y. C., Sargsyan, K., Wright, J. D., Chen, Y., Huang, Y., & Lim, C. (2024) · Research Square · doi:10.21203/rs.3.rs-3400169/v3
Prediction of Protein-Protein Interactions
Pathak, A., Tiwari, V. R., Menon, R., & Sowdhamini, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95502-7.00146-9 · Cited by 1
Lü, X., Wang, C., Tang, M., Li, J., Xia, Z., Fan, S., Jin, Y., & Yang, Z. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108450 · Cited by 1
Kuang, Z.-J., Li, Y.-K., Liu, Z., Zhao, J., Shi, L.-J., Akira-Kawai, & Wang, H. (2025) · bioRxiv · doi:10.1101/2025.05.23.655070
Muro, J. A. S., & Tavassoli, A. (2025) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2025.08.011
Gabele, A., Cihan, M., Sprang, M., Klein, M., Nurbekova, A., Romaniuk, K., Lemmermann, N. A. W., Tenzer, S., Andrade-Navarro, M. A., Bopp, T., et al. (2025) · STAR Protocols · doi:10.1016/j.xpro.2025.104184
Structural Impacts of Insertion Mutations on Protein-Protein Interfaces
Tessmer, J., Day, L., Trigubov, B., Galant, E., & Jagodzinski, F. (2025) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/3768322.3769030
Lee, S. H., Yellu, S., Lee, S. H., Cheong, J.-H., Kim, M., Park, S., & Hwang, T. H. (2025) · IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI ...) · doi:10.1109/bhi67747.2025.11269533
Metadata
- Authors
- Rosell, M., & Fernández-Recio, J.
- Affiliations
- Barcelona Supercomputing Center (ES)
- Department of Life Sciences, Barcelona Supercomputing Center (BSC), Barcelona, Spain
- ORCID
- Rosell, Mireia
- Venue
- Expert Opinion on Drug Discovery
- Publisher
- Informa UK Limited
- Published
- 2018-01-29
- Volume
- 13
- Issue
- 4
- Pages
- 327-338
- ISSN
- 1746-0441 (ISSN-L)
- 1746-045X
- OpenAlex
- W2791454012
- Cited by
- 105
- References
- 118
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 19 · 2023: 19 · 2022: 12 · 2021: 9 · 2020: 16 · 2019: 8 · 2018: 1
- FWCI
- 0.66
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Expert Opinion on Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (acceptedVersion, other-oa)
- UPCommons institutional repository (Universitat Politècnica de Catalunya) (acceptedVersion, other-oa)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (submittedVersion, public-domain)
- Funders
- the Spanish Ministry of Economy, Industry and Competitiveness (EFA086/15)
- EU Interreg V POCTEFA
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
- Keywords
- protein-protein interaction, hot spot residues, protein-protein interfaces, small molecule inhibitors, rational drug design, molecular docking, molecular dynamics, mutation analysis
- MeSH terms
- Humans, Models, Molecular, Proteins, Drug Design, Computational Biology, Drug Discovery, Molecular Dynamics Simulation, Molecular Docking Simulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review